Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

NCT07325864 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2026-01-08

No results posted yet for this study

Summary

investigate the molecular differences between primitive lung cancer and the metastatic site.

Conditions

  • NSCLC
  • Lung Cancer (Diagnosis)

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Lorenzo Spaggiari · European Institute of Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-18
Primary Completion
2027-06-30
Completion
2027-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07325864 on ClinicalTrials.gov